These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8000250)

  • 1. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B; Mühlbacher A; Melchior W
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient.
    Jongerius JM; van der Poel CL; van Leeuwen EF
    Vox Sang; 1998; 75(1):66-9. PubMed ID: 9745157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor.
    Almeida RP; Cardoso DD
    J Clin Virol; 2006 Jul; 36(3):231-4. PubMed ID: 16574475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HBV-DNA positive findings in HBsAg negative blood donors and patients].
    Hennig H; Dennin RH; Haase D; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1997; 34():26-30. PubMed ID: 9417346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications.
    El-Zaatari M; Kazma H; Naboulsi-Majzoub M; Haidar M; Ramlawi F; Mahfoud Z; Ramia S
    J Hosp Infect; 2007 Jul; 66(3):278-82. PubMed ID: 17540476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L; Holland P
    Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.